• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有黏液样分化的高级别浆液性卵巢癌:1例罕见且独特病例报告,提示从高级别浆液性癌的“SET”特征向“STEM”特征转变

High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.

作者信息

Hatano Yuichiro, Tamada Maho, Asano Nami, Hayasaki Yoh, Tomita Hiroyuki, Morishige Ken-Ichirou, Hara Akira

机构信息

Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.

Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.

出版信息

Diagn Pathol. 2019 Jan 12;14(1):4. doi: 10.1186/s13000-019-0781-9.

DOI:10.1186/s13000-019-0781-9
PMID:30636633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330567/
Abstract

BACKGROUND

High-grade serous carcinoma, a representative high-grade ovarian carcinoma, is believed to be closely associated with a TP53 mutation. Recently, this category of ovarian carcinoma has gained increasing attention owing to the recognition of morphological varieties of TP53-mutated high-grade ovarian carcinoma. Herein, we report the case of a patient with high-grade serous carcinoma with mucinous differentiation.

CASE PRESENTATION

A 59-year-old postmenopausal woman was referred to the gynecologist because of abnormal vaginal bleeding. The radiological assessment revealed an intrapelvic multicystic mass, which was interpreted as an early right ovarian cancer and then removed by radical surgery. Histologically, the cancer cells were found in the bilateral ovaries and para-aortic lymph nodes. The cancer cells showed high-grade nuclear atypia and various morphologies, including the solid, pseudo-endometrioid, transitional cell-like (SET) pattern, and mucin-producing patterns. Benign and/or borderline mucin-producing epithelium, serous tubal intraepithelial carcinoma, and endometriosis-related lesions were not observed. In immunohistochemistry analyses, the cancer cells were diffuse positive for p53; block positive for p16; partial positive for WT1, ER, PgR, CDX2 and PAX8; and negative for p40, p63, GATA3, Napsin A, and vimentin. The Ki-67 labeling index of the cancer cells was 60-80%. Direct sequencing revealed that the cancer cells contained a missense mutation (c.730G>A) in the TP53 gene.

CONCLUSION

Mucinous differentiation in high-grade serous carcinoma is a rare and unique ovarian tumor phenotype and it mimics the phenotypes of mucinous or seromucinous carcinoma. To avoid the misdiagnosis, extensive histological and immunohistochemical analyses should be performed when pathologists encounter high-grade mucin-producing ovarian carcinoma. The present case shows that the unusual histological characteristic of high-grade serous carcinoma, the "SET" feature, could be extended to the solid, transitional, endometrioid and mucinous-like (STEM) feature.

摘要

背景

高级别浆液性癌是一种典型的高级别卵巢癌,被认为与TP53突变密切相关。近年来,由于认识到TP53突变的高级别卵巢癌的形态学多样性,这类卵巢癌越来越受到关注。在此,我们报告一例具有黏液样分化的高级别浆液性癌患者的病例。

病例介绍

一名59岁的绝经后女性因异常阴道出血转诊至妇科医生处。影像学评估显示盆腔内多囊性肿块,被诊断为早期右侧卵巢癌,随后行根治性手术切除。组织学检查发现癌细胞存在于双侧卵巢和主动脉旁淋巴结。癌细胞表现出高级别核异型性和多种形态,包括实性、假子宫内膜样、移行细胞样(SET)模式和黏液产生模式。未观察到良性和/或交界性黏液产生上皮、浆液性输卵管上皮内癌和子宫内膜异位症相关病变。免疫组织化学分析显示,癌细胞p53弥漫阳性;p16块状阳性;WT1、ER、PgR、CDX2和PAX8部分阳性;p40、p63、GATA3、Napsin A和波形蛋白阴性。癌细胞的Ki-67标记指数为60-80%。直接测序显示癌细胞的TP53基因存在错义突变(c.730G>A)。

结论

高级别浆液性癌中的黏液样分化是一种罕见且独特的卵巢肿瘤表型,它模仿黏液性或浆液黏液性癌的表型。为避免误诊,病理学家在遇到高级别黏液产生性卵巢癌时应进行广泛的组织学和免疫组织化学分析。本病例表明,高级别浆液性癌不寻常的组织学特征,即“SET”特征,可能扩展为实性、移行性、子宫内膜样和黏液样(STEM)特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/13825799d9e1/13000_2019_781_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/59abe2c708a9/13000_2019_781_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/be1413c0aef9/13000_2019_781_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/13825799d9e1/13000_2019_781_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/59abe2c708a9/13000_2019_781_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/be1413c0aef9/13000_2019_781_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/699f/6330567/13825799d9e1/13000_2019_781_Fig3_HTML.jpg

相似文献

1
High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.伴有黏液样分化的高级别浆液性卵巢癌:1例罕见且独特病例报告,提示从高级别浆液性癌的“SET”特征向“STEM”特征转变
Diagn Pathol. 2019 Jan 12;14(1):4. doi: 10.1186/s13000-019-0781-9.
2
Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.最初诊断为卵巢子宫内膜样癌的肿瘤的形态学和免疫组化重新评估,重点关注高级别肿瘤。
Am J Surg Pathol. 2016 Mar;40(3):302-12. doi: 10.1097/PAS.0000000000000550.
3
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
4
Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.卵巢子宫内膜样癌和高级别浆液性癌的中肾样分化:与中肾样腺癌相比,其临床病理和分子特征不同。
Anticancer Res. 2021 Sep;41(9):4587-4601. doi: 10.21873/anticanres.15272.
5
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.Napsin A和WT 1是用于鉴别卵巢透明细胞癌与高级别浆液性癌的有用免疫组化标志物。
APMIS. 2018 Jan;126(1):45-55. doi: 10.1111/apm.12784. Epub 2017 Nov 20.
6
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.形态学可重复性、基因分型和免疫组织化学分析不支持卵巢浆液性黏液性癌这一类别。
Am J Surg Pathol. 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812.
7
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis.具有不一致p53特征的高级别浆液性癌:一例对高级别浆液性癌发生机制有新见解的病例报告
Diagn Pathol. 2018 Apr 27;13(1):24. doi: 10.1186/s13000-018-0702-3.
8
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].卵巢交界性肿瘤和癌的临床病理分析及细胞周期蛋白D1和p53的表达
Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32.
9
[Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].[输卵管伞端上皮内癌与盆腔高级别浆液性癌关系的初步研究]
Zhonghua Fu Chan Ke Za Zhi. 2011 Oct;46(10):724-8.
10
Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.低级别卵巢浆液性肿瘤(低级别浆液性癌和浆液性交界性肿瘤)伴高级别浆液性癌或未分化癌:一种不常见现象的系列病例报告。
Am J Surg Pathol. 2012 Mar;36(3):368-75. doi: 10.1097/PAS.0b013e31823732a9.

引用本文的文献

1
High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.BRCA 突变相关具有 sertoliform 形态的高级别浆液性卵巢癌:临床病理和分子分析。
Virchows Arch. 2023 Dec;483(6):879-883. doi: 10.1007/s00428-023-03556-z. Epub 2023 May 11.
2
Metastatic colon cancer of the small intestine diagnosed using genetic analysis: a case report.小肠转移性结直肠癌的基因分析诊断:一例报告。
Diagn Pathol. 2020 Aug 31;15(1):106. doi: 10.1186/s13000-020-01019-6.
3
High-grade serous carcinoma of fallopian tube with yolk sac tumor differentiation in a postmenopausal patient.

本文引用的文献

1
Tubo-Ovarian Transitional Cell Carcinoma and High-grade Serous Carcinoma Show Subtly Different Immunohistochemistry Profiles.卵巢-输卵管移行细胞癌和高级别浆液性癌的免疫组织化学表型略有不同。
Int J Gynecol Pathol. 2019 Nov;38(6):552-561. doi: 10.1097/PGP.0000000000000538.
2
Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.卵巢癌:至少五种具有不同组织学特征和分子遗传学特征的不同疾病。
Hum Pathol. 2018 Oct;80:11-27. doi: 10.1016/j.humpath.2018.06.018. Epub 2018 Jun 23.
3
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis.
一名绝经后患者的伴有卵黄囊瘤分化的高级别输卵管浆液性癌。
Int J Clin Exp Pathol. 2020 Jun 1;13(6):1415-1420. eCollection 2020.
4
Molecular Trajectory of and Mutations.和突变的分子轨迹。
Front Oncol. 2020 Mar 25;10:361. doi: 10.3389/fonc.2020.00361. eCollection 2020.
5
A Comprehensive Review of Ovarian Serous Carcinoma.卵巢浆液性癌的全面综述。
Adv Anat Pathol. 2019 Sep;26(5):329-339. doi: 10.1097/PAP.0000000000000243.
具有不一致p53特征的高级别浆液性癌:一例对高级别浆液性癌发生机制有新见解的病例报告
Diagn Pathol. 2018 Apr 27;13(1):24. doi: 10.1186/s13000-018-0702-3.
4
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.芦卡帕利维持治疗铂类化疗后缓解的复发性卵巢癌(ARIEL3):一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12.
5
TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer.TP53突变介导的基因组不稳定性诱导上皮性卵巢癌化疗耐药性的演变和复发。
Diagn Pathol. 2017 Feb 2;12(1):16. doi: 10.1186/s13000-017-0605-8.
6
Optimized p53 immunohistochemistry is an accurate predictor of mutation in ovarian carcinoma.优化的p53免疫组化是卵巢癌突变的准确预测指标。
J Pathol Clin Res. 2016 Jul 13;2(4):247-258. doi: 10.1002/cjp2.53. eCollection 2016 Oct.
7
Ovarian Epithelial Inclusions With Mucinous Differentiation: A Clinicopathologic Study of 42 Cases.伴有黏液分化的卵巢上皮性包涵体:42例临床病理研究
Int J Gynecol Pathol. 2017 Jul;36(4):372-376. doi: 10.1097/PGP.0000000000000348.
8
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.尼拉帕利维持治疗铂敏感复发性卵巢癌。
N Engl J Med. 2016 Dec 1;375(22):2154-2164. doi: 10.1056/NEJMoa1611310. Epub 2016 Oct 7.
9
The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.卵巢癌发生的二元模型:重新审视、修订与扩展
Am J Pathol. 2016 Apr;186(4):733-47. doi: 10.1016/j.ajpath.2015.11.011.
10
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing.一种用于卵巢癌分型的免疫组织化学算法
Int J Gynecol Pathol. 2016 Sep;35(5):430-41. doi: 10.1097/PGP.0000000000000274.